🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Antonio DiGiandomenico

AstraZeneca (France)

ORCID: 0000-0003-1745-647X

Also affiliated with AstraZeneca (Netherlands)

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.

39 citations

Lindsay Jackson, Yvonne Yau, Courtney Reichhardt, Trevor Beaudoin, Stephanie O. Uwumarenogie +10 more

34 citations

Travis B. Nielsen, Peggy Lu, Yuli Talyansky, Matt Slarve, Hernan Reza +9 more

N/A
0DataRank · unranked
12 citations

Antonio DiGiandomenico, Vishnu Raghuram, Marc Schulman, Jennifer M. Scarff, Michael R. Davis +4 more

N/A
0DataRank · unranked
1 citations

Antonio DiGiandomenico, Vishnu Raghuram, Marc Schulman, Jennifer M. Scarff, Michael R. Davis +4 more